| April Dannielle Vasquez, RPH | |
|
1301 Andrews Ave, Ozark, AL 36360-3717 | |
| (334) 432-7085 | |
| (334) 432-7086 |
| Full Name | April Dannielle Vasquez |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1301 Andrews Ave, Ozark, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396331294 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 12441 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| April Dannielle Vasquez, RPH 1301 Andrews Ave, Ozark, AL 36360-3717 Ph: (334) 432-7085 | April Dannielle Vasquez, RPH 1301 Andrews Ave, Ozark, AL 36360-3717 Ph: (334) 432-7085 |
News Archive
Phoenix-Researchers at the Translational Genomics Research Institute (TGen) and Kronos Science Laboratories, an affiliate of Phoenix-based Kronos Optimal Health Company, have initiated a study with unprecedented power to identify genes that are involved in the development of Alzheimer's disease, the most common form of disabling memory and thinking problems in older persons.
RTI Biologics Inc., a leading provider of orthopedic and other biologic implants, was recognized in the 2011 fourth edition of Evolution magazine for achieving a 98.7 percent equipment performance rating for its facilities and processing equipment. Evolution magazine is published by SKF Group, a global company which provides condition monitoring to RTI.
Behavioral abnormalities are traditionally thought to originate in the brain. But a new study by researchers at Albert Einstein College of Medicine of Yeshiva University has found that inner-ear dysfunction can directly cause neurological changes that increase hyperactivity.
Human diseases caused by misfolded proteins known as prions are some of most rare yet terrifying on the planet—incurable with disturbing symptoms that include dementia, personality shifts, hallucinations and coordination problems.
The U.S. Food and Drug Administration today approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called Factor VIII (FVIII) inhibitors.
› Verified 7 days ago
Christopher Stevens, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 126 Hospital Ave, Ozark, AL 36360 Phone: 334-774-2601 Fax: 334-774-9179 | |
Taylor M Bradford, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1537 S Us Highway 231, Ozark, AL 36360 Phone: 334-774-0272 | |
Miss Reid Nicole Davis, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1537 S Us Highway 231, Ozark, AL 36360 Phone: 334-774-5508 | |
Taylor Moody, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1537 S Us Highway 231, Ozark, AL 36360 Phone: 334-774-5508 | |
Zach Mcleod, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 591 S Union Ave, Ozark, AL 36360 Phone: 334-774-8505 | |
Mr. James C Harris, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1649 E Roy Parker Rd, Ozark, AL 36360 Phone: 334-791-5290 |